ATE358135T1 - Phagen-abhängige superproduktion biologisch aktiver proteine und peptide - Google Patents

Phagen-abhängige superproduktion biologisch aktiver proteine und peptide

Info

Publication number
ATE358135T1
ATE358135T1 AT01964014T AT01964014T ATE358135T1 AT E358135 T1 ATE358135 T1 AT E358135T1 AT 01964014 T AT01964014 T AT 01964014T AT 01964014 T AT01964014 T AT 01964014T AT E358135 T1 ATE358135 T1 AT E358135T1
Authority
AT
Austria
Prior art keywords
phage
biologically active
active proteins
peptides
cells
Prior art date
Application number
AT01964014T
Other languages
English (en)
Inventor
Vitaliy A Kordyum
Svitlana I Chernykh
Iryna Yu Slavchenko
Oleksandr F Vozianov
Original Assignee
Phage Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phage Biotechnology Corp filed Critical Phage Biotechnology Corp
Application granted granted Critical
Publication of ATE358135T1 publication Critical patent/ATE358135T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT01964014T 2000-08-15 2001-08-15 Phagen-abhängige superproduktion biologisch aktiver proteine und peptide ATE358135T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22543700P 2000-08-15 2000-08-15

Publications (1)

Publication Number Publication Date
ATE358135T1 true ATE358135T1 (de) 2007-04-15

Family

ID=22844863

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964014T ATE358135T1 (de) 2000-08-15 2001-08-15 Phagen-abhängige superproduktion biologisch aktiver proteine und peptide

Country Status (10)

Country Link
US (1) US6773899B2 (de)
EP (1) EP1309604B1 (de)
JP (1) JP2004528005A (de)
KR (1) KR100761486B1 (de)
AT (1) ATE358135T1 (de)
AU (2) AU8491401A (de)
CA (1) CA2419203A1 (de)
DE (1) DE60127561T2 (de)
ES (1) ES2284677T3 (de)
WO (1) WO2002014468A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7252818B2 (en) * 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
US6268178B1 (en) * 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
US20050129711A1 (en) * 2002-11-14 2005-06-16 Janakiraman Ramachandran Incapacitated whole-cell immunogenic bacterial compositions produced by recombinant expression
US20090311742A1 (en) * 2005-02-22 2009-12-17 David Tabaczynski Phage-Derived Vectors and Methods for Protein Expression
WO2010052335A1 (en) * 2008-11-10 2010-05-14 Novo Nordisk A/S E. coli bl21 strain lacking a functional group ii capsular gene cluster
TWI434698B (zh) * 2009-08-14 2014-04-21 Eu Sol Biotech Co Ltd 人類酸性纖維母細胞生長因子之醫藥用途
US20120309011A1 (en) * 2009-11-02 2012-12-06 Salk Institute For Biological Studies Targeting of modifying enzymes for protein evolution
AR087330A1 (es) * 2011-07-07 2014-03-19 Delphi Genetics Sa Fago modificado geneticamente y uso del mismo
US9920323B2 (en) 2011-07-07 2018-03-20 Delphi Genetics Genetically modified phage and use thereof
EP2543720A1 (de) * 2011-07-07 2013-01-09 Delphi Genetics Genetisch modifizierte Phagen und Verwendung dafür
EP3158054B1 (de) 2014-06-17 2025-02-19 Crown Laboratories, Inc. Gentechnisch modifizierte bakterien und verfahren zur genetischen modifikation von bakterien
DE102014212675A1 (de) * 2014-07-01 2016-01-07 Wacker Chemie Ag T7-Expressionssystem, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung von rekombinanten Proteinen
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
WO2019068006A1 (en) * 2017-09-29 2019-04-04 The Charles Stark Draper Laboratory, Inc. CELLULAR LYSE CONTROLLED BY STIMULUS
CN110172451A (zh) * 2019-05-05 2019-08-27 昆明理工大学 一种高通量分离噬菌体的方法
BR112022026237A2 (pt) 2020-06-23 2023-01-17 Crown Laboratories Inc Formulações probióticas para a pele
CN113881641B (zh) * 2021-10-19 2023-06-23 广西大学 一株大肠杆菌噬菌体ep01及其应用
CN118546850A (zh) * 2022-09-29 2024-08-27 浙江大学杭州国际科创中心 高产重组蛋白的需钠弧菌工程菌及其应用
CN116143886B (zh) * 2022-10-12 2025-04-01 中国海洋大学 铜绿假单胞菌噬菌体编码的Gp21蛋白及其在抑制大肠杆菌噬菌体感染方面的应用
CN116179525A (zh) * 2023-01-18 2023-05-30 南京农业大学 一种噬菌体裂解酶及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1089119A1 (ru) * 1982-11-29 1984-04-30 Институт Молекулярной Биологии И Генетики Ан Усср Способ получени @ -лактамазы
GB2143238A (en) * 1983-03-31 1985-02-06 Dr Anthony Stuart Breeze A method for enzyme liberation from bacterial cells
US4637980A (en) * 1983-08-09 1987-01-20 Smithkline Beckman Corporation Externalization of products of bacteria
JP2803184B2 (ja) * 1988-07-04 1998-09-24 武田薬品工業株式会社 酸性線維芽細胞成長因子の抗体，その用途およびペプチド
GB2223496B (en) * 1988-08-08 1992-05-27 British Bio Technology Synthetic gene encoding mature human acid fibroblast growth factor
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
JPH0343088A (ja) * 1989-09-29 1991-02-25 Takeda Chem Ind Ltd ａＦＧＦ蛋白質の製造法
US6268178B1 (en) * 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides

Also Published As

Publication number Publication date
DE60127561D1 (de) 2007-05-10
KR100761486B1 (ko) 2007-10-04
KR20030031979A (ko) 2003-04-23
WO2002014468A9 (en) 2003-04-03
WO2002014468A2 (en) 2002-02-21
WO2002014468A3 (en) 2002-05-10
EP1309604B1 (de) 2007-03-28
JP2004528005A (ja) 2004-09-16
CA2419203A1 (en) 2002-02-21
EP1309604A4 (de) 2006-10-11
US6773899B2 (en) 2004-08-10
US20020090678A1 (en) 2002-07-11
AU8491401A (en) 2002-02-25
AU2001284914B2 (en) 2006-02-09
EP1309604A2 (de) 2003-05-14
ES2284677T3 (es) 2007-11-16
DE60127561T2 (de) 2007-12-13

Similar Documents

Publication Publication Date Title
ATE358135T1 (de) Phagen-abhängige superproduktion biologisch aktiver proteine und peptide
Stammen et al. High-yield intra-and extracellular protein production using Bacillus megaterium
Kevany et al. Characterization of the complete zwittermicin A biosynthesis gene cluster from Bacillus cereus
Pfister et al. Molecular analysis of Methanobacterium phage ΨM2
Gupta et al. An introduction to biotechnology
CN113584058B (zh) 信号肽相关序列及其在蛋白质合成中的应用
KR20240055073A (ko) 클래스 ii, v형 crispr 시스템
Ughy et al. Phycobilisome rod mutants in Synechocystis sp. strain PCC6803
Nasr et al. Covalently circularized nanodiscs; challenges and applications
DK0941318T3 (da) Håndvægtformede konstruerede ekspressionssystemer til genterapi
AR062019A1 (es) Gen de bacillus thuringiensis con actividad contra lepidopteros
CN117965408A (zh) 酰基氨基酸的产生
Nguyen et al. Analysis and application of Bacillus subtilis sortases to anchor recombinant proteins on the cell wall
KR20200106171A (ko) 스타필로코쿠스 박테리아의 영양 요구성 균주
Rocha et al. Expression of Pseudomonas aeruginosa PAO1 Chitinase C in Escherichia coli BL21 (DE3)
WO2003076561A3 (en) Recombinase fusion protein with enhanced cellular uptake
JP7092355B2 (ja) 増殖とタンパク質生成との分離
CN105062992A (zh) 一种细胞内溶素和编码此细胞内溶素的多核苷酸
JP5497295B2 (ja) マイクロギニン産生タンパク質、及びマイクロギニン遺伝子クラスターをコードする核酸、並びにマイクロギニンの製造方法
Chen et al. A novel molecular chaperone GroEL2 from Rhodococcus ruber and its fusion chimera with nitrile hydratase for co-enhanced activity and stability
DE60019411D1 (de) Phage-abhängige superproduktion von biologisch aktiven proteinen und peptiden
Holmqvist et al. Characterization of the hupSL promoter activity in Nostoc punctiforme ATCC 29133
Liu et al. Mutational switching of a yeast tRNA synthetase into a mammalian-like synthetase cytokine
Di Lorenzo et al. Tandem heterocyclization domains in a nonribosomal peptide synthetase essential for siderophore biosynthesis in Vibrio anguillarum
Yu et al. Draft genome sequence, disease-resistance genes, and phenotype of a Paenibacillus terrae strain (NK3-4) with the potential to control plant diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1309604

Country of ref document: EP

EEIH Change in the person of patent owner